Why Are People Injecting Themselves with Peptides? The New Yorker The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives